Efficacy of ruxolitinib in subcutaneous panniculitis-like T-cell lymphoma and hemophagocytic lymphohistiocytosis.

Authors	Romain Lévy, Mathieu Fusaro, Frédéric Guerin, Ahmed Chetouani, Despina Moshous, Alain Fischer, Geneviève de Saint Basile, Fernando E Sepulveda, Bénédicte Neven
Journal	Blood advances (Blood Adv) Vol. 4 Issue 7 Pg. 1383-1387 (04 14 2020) ISSN: 2473-9537 [Electronic] United States
PMID	32271897 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References	Nitriles Pyrazoles Pyrimidines ruxolitinib
Topics	Humans Lymphohistiocytosis, Hemophagocytic (drug therapy) Lymphoma, T-Cell (drug therapy) Nitriles Panniculitis (drug therapy) Pyrazoles Pyrimidines

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!